Endometrial response to hormone replacement therapy as assessed by expression of insulin-like growth factor-binding protein-1 in the endometrium

Fertility and Sterility

Volumn 65, Issue 4, 1996, Pages 776-782

  Suhonen, S ^a   Haukkamaa, M ^a   Holmstrom, T ^a   Lahteenmaki, P ^a   Rutanen, E M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

continuous combined hormone replacement therapy; decidualization; Endometrial response; IGFBP 1; intrauterine progestin; levonorgestrel releasing intrauterine device

Indexed keywords

GESTAGEN; LEVONORGESTREL; SOMATOMEDIN BINDING PROTEIN;

ARTICLE; CLINICAL ARTICLE; DECIDUALIZATION; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS;

EID: 0029871353     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0015-0282(16)58213-2     Document Type: Article

References (25)

1. R.A. Lobo The role of progestins in hormone replacement therapy Am J Obstet Gynecol 166 1992 1997 2004
2. S.G. Prough S. Aksel R.H. Wiebe J. Shepherd Continuous es-trogen/progestin therapy in menopause Am J Obstet Gynecol 157 1987 1449 1453
3. M.I. Whitehead P.T. Townsend J. Pryse-Davies T.A. Ryder R.J.B. King Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium N Engl J Med 305 1981 1599 1605
4. L.C. Giudice Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine Fertil Steril 61 1994 1 17
5. L.C. Giudice B.A. Dsupin I.H. Jin T.H. Vu A.R. Hoffman Differential expression of mRNAs encoding insulin-like growth factors and their receptors in human uterine endometrium and decidua J Clin Endocrinol Metab 76 1993 1115 1122
6. S. Shimasaki N. Ling Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6) Prog Growth Factor Res 3 1992 243 266
7. E.-M. Rutanen Insulin-like growth factor binding protein-1 Semin Reprod Endocrinol 10 1992 154 163
8. M. Julkunen R. Koistinen A.-M. Suikkari M. Seppälä O.A. Jänne Identification by hybridization histochemistry of human endometrial cells expressing mRNAs encoding a uterine b-lactoglobulin homologue and insulin-like growth factor-binding protein-1 Mol Endocrinol 4 1990 700 707
9. E.-M. Rutanen E. Gonzales J. Said G.D. Braunstein Immuno-histochemical localization of the insulin-like growth factor binding protein-1 in female reproductive tissues by monoclonal antibodies Endocr Pathol 2 1991 132 138
10. S.G. Silverberg M. Haukkamaa H. Arko C.G. Nilsson T. Luuk-kainen Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices Int J Gynecol Pathol 5 1986 235 241
11. F. Pekonen T. Nyman P. Lähteenmäki M. Haukkamaa E.-M. Rutanen Intrauterine progestin induces continuous insulinlike growth factor-binding protein-1 production in the human endometrium J Clin Endocrinol Metab 75 1992 660 664
12. K. Andersson L.-A. Mattsson G. Rybo E. Stadberg Intrauterine release of levonorgestrel—a new way of adding progestogen in hormone replacement therapy Obstet Gynecol 79 1992 963 967
13. T.H. Raudaskoski E.I. Lahti A.J. Kauppila M.A. Apaja-Sarkkinen T.J. Laatikainen Transdermal estradiol with a levonorgestrel-releasing intrauterine device: clinical and endometrial responses Am J Obstet Gynecol 172 1995 114 119
14. S.P. Suhonen H.O. Allonen P. Lähteenmäki Sustained-release estradiol implants and a levonorgestrel-releasing intrauterine device in hormone replacement therapy Am J Obstet Gynecol 172 1995 562 567
15. S.P. Suhonen T. Holmström H.O. Allonen P. Lähteenmäki Intrauterine and subdermal progestin administration in postmenopausal hormone replacement therapy Fertil Steril 63 1995 336 342
16. E.-M. Rutanen T. Kärkkäinen C. Lundqvist F. Pekonen O. Ritvos P. Tanner Monoclonal antibodies to the 27−34K insulin-like growth factor-binding protein Biochem Biophys Res Commun 152 1988 208 215
17. E.-M. Rutanen S. Partanen F. Pekonen Decidual transformation of human extrauterine mesenchymal cells is associated with the appearance of insulin-like growth factor-binding protein-1 J Clin Endocrinol Metab 77 1991 27 31
18. J. Zhou B.A. Dsupin L.C. Giudice C.A. Brondy Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle J Clin Endocrinol Metab 79 1994 1723 1734
19. T. Wahlström M. Seppälä Placental protein 12 (PP 12) is induced in the endometrium by progesterone Fertil Steril 41 1984 781 784
20. M. Westwood J.M. Gibson A.J. Davies E.J. Young A. White The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy J Clin Endocrinol Metab 79 1994 1735 1741
21. M. Friedlander P. de-Souza E. Segelov Risk factors, epidemiology, screening, and prognostic factors in female genital cancer Curr Opin Oncol 4 1992 913 922
22. C.G. Nilsson M. Haukkamaa H. Vierola T. Luukkainen Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD Clin Endocrinol (Oxf) 17 1982 529 536
23. O. Jänne P. Ylöstalo Endometrial estrogen and progestin receptors in women bearing progesterone-releasing intrauterine device Contraception 22 1980 19 23
24. S.T. Shaw Jr. L.K. Macauly R. Aznar A. Gonzalez-Angulo S. Roy Effects of progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study Am J Obstet Gynecol 141 1981 821 827
25. E.-M. Rutanen T. Nyman P. Lehtovirta M. Ämmälä F. Pekonen Suppressed expression of insulin-like growth factor-binding protein-1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors Int J Cancer 59 1994 1 6